
PTC THERAPEUTICS, INC. PTCT
PTC THERAPEUTICS, INC. statistics & valuation
P / FCF10.0×
Net margin39.4%
FCF margin40.6%
Return on capital44.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Net margin (%)Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Operating margin | 50.1% | -37.5% | -46.9% | -64.0% | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% |
| Net margin | 39.4% | -45.0% | -66.8% | -80.0% | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% |
| FCF margin | 40.6% | -14.2% | -19.9% | -55.6% | -51.9% | -55.7% | -36.6% | -13.1% | -6.8% | -127.4% |
| Return on assets | 23.5% | -21.3% | -33.1% | -32.8% | -27.0% | -19.8% | -15.5% | -11.4% | -20.2% | -52.8% |
| Return on equity | -332.5% | 33.1% | 76.6% | 161.1% | -36432.6% | -90.9% | -42.3% | -36.5% | -50.5% | -118.8% |
| Debt / equity | — | -0.26× | -0.35× | -1.65× | 196.03× | 0.64× | 0.49× | 0.40× | 0.93× | 0.82× |
| Current ratio | 2.35 | 2.35 | 2.02 | 1.71 | 1.87 | 4.44 | 3.30 | 1.92 | 3.04 | 5.27 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.